Circassia Pharmaceuticals (GB:NIOX) has released an update.
Circassia Pharmaceuticals, trading as NIOX Group plc, has announced an update to their total voting rights. The company’s issued share capital now stands at 424,045,460 Ordinary Shares following the exercise of employee share options. Shareholders can use this new share count as the denominator for the purpose of notifications under the FCA’s Disclosure Guidance and Transparency Rules.
For further insights into GB:NIOX stock, check out TipRanks’ Stock Analysis page.
